The Aim-quoted company said there were “early indications” that results for the year as a whole would now be at the higher end of the board’s expectations.
Sales growth has been strongest in its network and industrial systems divisions which provide products to the security and oil and gas markets. The group’s order book at the year end was around £34.7 million compared to £27.3m last year.
Shares in the company rose on the trading update and are now up by more than a third over the past 12 months.
Despite the rise, last week non-executive director Stephen Coggins purchased 2,080 shares at 237p each. He now holds 13,080 shares.
• Sarah Bertolotti, finance director at drinks group Blavod Wines and Spirits, has bought 124,667 shares at 1.72p each. It was her first investment in the group. Last month the company announced pre-tax losses increased to £393,000 in the six months to the end of September.
• Jean Stéphenne, president and general manager of the biologicals division at drugs giant GlaxoSmithKline, has sold 20,000 shares at 1,440p.
• Brendan Nelson, a non-executive BP director, has bought 11,040 shares at 449p.
• Sir Michael Rake, a non-executive director of banking group Barclays, has increased his stake with the purchase of 5,914 shares at 167p per share. He now holds 35,213 shares.
• Lynton Barker, executive chairman of risk management software group Active Risk, has purchased 400,000 shares at 37p each, to take his holding to 556,250 shares.
• Shirley Bowers, the wife of Anthony Bowers, a non-executive director of technology group Quindell Portfolio, has bought 57,789 shares at 5.15p. The family now holds 1.22 million shares.
• Andrew Grant, chief executive of Jarvis Securities, has bought 25,780 shares at 157.5p each per share. His total interests in the company have risen to 6.6 million shares.